DMII
Income statement / Annual
Last year (2025), Drugs Made In America Acquisition II Corp's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Drugs Made In America Acquisition II Corp's net income was $4.19 M.
See Drugs Made In America Acquisition II Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
| Period Ended |
12/31/2025 |
12/31/2024 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$488.39 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$488.39 K
|
$151.72 K
|
| Other Expenses |
$812.11 K
|
$0.00
|
| Operating Expenses |
$1.30 M
|
$151.72 K
|
| Cost And Expenses |
$1.30 M
|
$151.72 K
|
| Interest Income |
$4.93 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
| EBITDA |
-$1.30 M |
-$151.72 K |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$5.49 M
|
$0.00
|
| Income Before Tax |
$4.19 M
|
-$151.72 K
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
| Net Income |
$4.19 M
|
-$151.72 K
|
| Net Income Ratio |
0
|
0
|
| EPS |
0.16 |
-0.0024 |
| EPS Diluted |
0.15 |
-0.0024 |
| Weighted Average Shares Out |
$13.29 M
|
$63.70 M
|
| Weighted Average Shares Out Diluted |
$13.29 M
|
$63.70 M
|
| Link |
|
|
